RESEARCH-USE BIOSIMILAR ANTIBODY
Tregalizumab
Monoclonal antibody · IgG1
Tregalizumab is a humanized anti-human CD4 monoclonal antibody (IgG1 type) that selectively activates the suppressive properties of regulatory T cells (Tregs) in vitro. Tregalizumab can be used in the research of autoimmune diseases (resulting from insufficient Treg activity) and allergies.
TARGETCD4
YMonoclonal antibody
CATALOGSC-BS-081
CATALOG NUMBERSC-BS-081
MOLECULAR WEIGHTApprox. 147.42 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tregalizumab is a humanized anti-human CD4 monoclonal antibody (IgG1 type) that selectively activates the suppressive properties of regulatory T cells (Tregs) in vitro. Tregalizumab can be used in the research of autoimmune diseases (resulting from insufficient Treg activity) and allergies.
Tregalizumab is a recombinant research-use antibody directed against CD4.